CPSC recall 19742 — TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)

TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)

CPSC · 19742 · published 2019-04-25

CPSC campaign 19742

Hazard

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.

Remedy

Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

TriDerma, of Corona, Calif.

Pain Relief Cream with Lidocaine

TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)

Affected products

Brands in this recall